Plasma insulin-like growth factor I levels in the elderly: Relation to plasma dehydroepiandrosterone sulfate levels, nutritional status, health and mortality

被引:22
|
作者
Raynaud-Simon, A [1 ]
Lafont, S
Berr, C
Dartigues, JF
Baulieu, EE
Le Bouc, Y
机构
[1] Hop Charles Foix, Unite Med Nutr Geriatr, AP HP, F-94205 Ivry, France
[2] Hop Trousseau, Lab Explorat Fonctionnelles Endocriniennes, Paris, France
[3] Hop St Antoine, F-75571 Paris, France
[4] Univ Bordeaux 2, INSERM U330, Bordeaux, France
[5] Hop La Pitie Salpetriere, INSERM U360, Paris, France
[6] Hop Bicetre, INSERm U488, Le Kremlin Bicetre, France
关键词
insulin-like growth factor I; aging dehydroepiandrosterone sulfate; nutrition; mortality; cognition; depression; functional disability;
D O I
10.1159/000052799
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Insulin-like growth factor I (IGF-I) has beneficial metabolic effects. Because plasma IGF-I levels have been reported to be enhanced by dehydroepiandrosterone (DHEA) administration, it has been suggested that the IGF-I may be implicated in some of the reported associations between low DHEA sulfate (DHEAS) levels and impaired health measures in elderly subjects. The nutritional status, which also regulates plasma IGF-I levels, is also an important determinant of health outcome. Objective:We sought to investigate the associations between plasma IGF-I revels and plasma DHEAS levels, nutritional status, health, and mortality in the elderly. Methods: In 256 community-dwelling subjects aged 65-101 years, enrolled in the Paquid study, a health questionnaire was used to a certain their functional disabilities, any history of medical disorders, self-perceived health, depressive symptoms, and their cognitive function. Biological measurements included levels of plasma IGF-I, albumin, transthyretin, and DHEAS. Mortality data were available for 6 years following blood sampling. Results: In this elderly population with no impairment in nutritional status, the plasma IGF-I levels decreased significantly with age (p = 0.02). The plasma IGF-I levels correlated positively with those of transthyretin (p = 0.0001). IGF-I also correlated with DHEAS (p = 0.04), but the correlation did not remain significant after adjustment for age. As opposed to SDHEA, the plasma IGF-I revels did not correlate with the results from the hearth questionnaire. The baseline IGF-I values in the highest tertile were associated with a higher risk of short-term mortality than those in the lowest tertile (RR = 8.4 at 2 years, p = 0.007). Conclusions: Our results suggest that IGF-I is not connected with the association between low plasma DHEAS levels and the impaired results from the health questionnaire. The relationship between plasma IGF-I highest levels and mortality should be further explored. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:198 / 206
页数:9
相关论文
共 50 条
  • [31] PLASMA-LEVELS OF INSULIN-LIKE GROWTH FACTOR-I AND ITS BINDING-PROTEIN IN POLYCYSTIC-OVARY-SYNDROME
    IWASHITA, M
    MIMURO, T
    WATANABE, M
    SETOYAMA, T
    MATSUO, A
    ADACHI, T
    TAKEDA, Y
    SAKAMOTO, S
    HORMONE RESEARCH, 1990, 33 : 21 - 26
  • [32] Insulin-Like Growth Factor I Serum Levels Influence Ischemic Stroke Outcome
    De Smedt, Ann
    Brouns, Raf
    Uyttenboogaart, Maarten
    De Raedt, Sylvie
    Moens, Maarten
    Wilczak, Nadine
    Luijckx, Gert-Jan
    De Keyser, Jacques
    STROKE, 2011, 42 (08) : 2180 - 2185
  • [33] Physical activity and dehydroepiandrosterone sulphate, insulin-like growth factor I and testosterone in healthy active elderly people
    Bonnefoy, M
    Köstka, T
    Patricot, MC
    Berthouze, SE
    Mathian, B
    Lacour, JR
    AGE AND AGEING, 1998, 27 (06) : 745 - 751
  • [34] Circulating levels of insulin-like growth factor-I and risk of ovarian cancer
    Lukanova, A
    Lundin, E
    Toniolo, P
    Micheli, A
    Akhmedkhanov, A
    Rinaldi, S
    Muti, P
    Lenner, P
    Biessy, C
    Krogh, V
    Zeleniuch-Jacquotte, A
    Berrino, F
    Hallmans, G
    Riboli, E
    Kaaks, R
    INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (06) : 549 - 554
  • [35] THE EFFECT OF OVARIAN-FUNCTION ON INSULIN-LIKE GROWTH FACTOR-I PLASMA-LEVELS AND HEPATIC IGF-I MESSENGER-RNA LEVELS IN DIABETIC RATS TREATED WITH INSULIN
    ROGERS, DG
    VALDES, CT
    ELKINDHIRSCH, KE
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1990, 8 (03) : 235 - 242
  • [36] Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis
    C. M. Gordon
    E. Binello
    M. S. LeBoff
    M. E. Wohl
    C. J. Rosen
    A. A. Colin
    Osteoporosis International, 2006, 17 : 783 - 790
  • [37] The relation between insulin-like growth factor 1 levels and risk of depression in ischemic stroke
    Zhang, Wei
    Wang, Wo
    Kuang, Li
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (02) : E228 - E233
  • [38] Insulin-Like Growth Factor-I is a Marker for the Nutritional State
    Hawkes, Colin P.
    Grimberg, Adda
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2015, 13 (02) : 499 - 511
  • [39] Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis
    Gordon, CM
    Binello, E
    LeBoff, MS
    Wohl, ME
    Rosen, CJ
    Colin, AA
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 (05) : 783 - 790
  • [40] LOW PLASMA-LEVELS OF INSULIN-LIKE GROWTH FACTOR-I (IGF-1) IN MALE-PATIENTS WITH IDIOPATHIC OSTEOPOROSIS
    LJUNGHALL, S
    JOHANSSON, AG
    BURMAN, P
    KAMPE, O
    LINDH, E
    KARLSSON, FA
    JOURNAL OF INTERNAL MEDICINE, 1992, 232 (01) : 59 - 64